Blanket Purchase Agreement 36C24923A0030
Award Date
9/15/23
Last Date to Order
12/31/25
Federal Agency
Veterans Integrated Service Network 9
Awardee
Therakos, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 to Therakos, Inc., a foreign-owned, for-profit corporation. The $163,904 single-award contract will provide Original Equipment Manufacturer (OEM) Preventive Maintenance (PM) for CELLEX equipment, with an ultimate completion date of July 30, 2029. The contract includes a $32,456 Firm Fixed Price Delivery Order for full service maintenance, including corrective and...
This federal contract IDV is a multiple-award Federal Supply Schedule (FSS) contract under Schedule 61-IB for Pharmaceuticals and Drugs, awarded by the Department of Veterans Affairs (VA) to Therakos, Inc., a foreign-owned, for-profit corporation. The contract has a ceiling value of $750,000 and a period of performance through January 2026. Therakos is a key supplier of specialized photopheresis products and services to federal healthcare facilities, particularly within the VA system. The...
The U.S. Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) contract to Calliditas Therapeutics US Inc., a foreign-owned, for-profit pharmaceutical company, to provide the medication TARPEYO. This BPA, valued at $1,750,000 and running through April 2026, designates Calliditas Therapeutics US Inc. as the sole approved supplier of TARPEYO to VA medical facilities nationwide. TARPEYO is an innovative treatment for uncontrolled protein in the urine due to primary...
The U.S. Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Blanket Purchase Agreement (BPA) to Sobi, Inc., a foreign-owned, for-profit pharmaceutical company, to provide the drugs TEGSEDI and ORFADIN. The BPA, valued up to $11.75 million, covers the period from October 2021 through September 2025. Sobi, Inc. also holds a multiple award schedule contract with the VA valued at up to $78 million through July 2025 for pharmaceutical products under the Federal...
The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals. The $7.5 million single-award BPA, issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), covers the delivery of PLUVICTO and LUTATHERA, which are radiopharmaceutical products used for cancer treatment and diagnostic imaging. The VA has awarded Advanced Accelerator...
The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products, under the company's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs. The single-award BPA, valued at over $13 million, is for the supply of the oncology medication ICLUSIG (ponatinib) to various VA Medical Centers and Veterans Integrated Service Networks (VISNs)...
The Department of Veterans Affairs (VA) awarded a Federal Supply Schedule (FSS) contract, valued at up to $3.5 million, to Calliditas Therapeutics US Inc., a foreign-owned, for-profit pharmaceutical company. The contract, under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, facilitates the procurement of TARPEYO, an innovative treatment for uncontrolled protein in urine due to primary immunoglobulin A nephropathy, a serious renal condition impacting some veterans. In addition to the FSS...
The U.S. Department of Veterans Affairs (VA) has awarded Immunocore Commercial LLC, a foreign-owned, for-profit manufacturer of goods, a Federal Supply Schedule (FSS) Indefinite Delivery Vehicle (IDV) contract (ID: 36F79724D0026) with a $225,000 ceiling value. This multiple-award IDV, which runs through November 14, 2028, covers Federal Supply Classification 65 I B, encompassing drugs, pharmaceuticals, and hematology-related products. Immunocore Commercial LLC has received multiple firm...
The U.S. Department of Veterans Affairs (VA) has awarded a multiple award Federal Supply Schedule (FSS-61-IB) contract to Sobi, Inc., a foreign-owned, for-profit pharmaceutical company, with a ceiling value of $78 million through July 2025. This contract enables the VA to procure pharmaceuticals and drug products, such as TEGSEDI and ORFADIN, to support healthcare services for veterans. Additionally, the VA National Acquisition Center has awarded a single-award Blanket Purchase Agreement (BPA)...
The Department of Veterans Affairs National Acquisition Center has awarded a Blanket Purchase Agreement (BPA) to Helsinn Therapeutics (U.S.), Inc., a for-profit pharmaceutical manufacturer, to provide the drug VALCHLOR. VALCHLOR is used to treat cutaneous T-cell lymphoma. The BPA has a ceiling value of $15,475,951.95 and a period of performance through February 2025. This BPA allows VA medical facilities to efficiently procure VALCHLOR on an as-needed basis to treat veterans with this condition....